Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
VERA
#1648
Vera Therapeutics, Inc. Class A Common Stock
44.360
0
USD
+1.49%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+1.49%
Aylık Değişim
+9.34%
6 aylık değişim
+49.16%
Yıllık Değişim
+49.16%
Önceki Kapanış
43.710
0
Open
44.360
0
Bid
Ask
Low
44.360
0
High
44.360
0
Hacim
115
Piyasalar
ABD Borsası
Sağlık Hizmetleri
VERA
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
26.74 M
44.26 M
54.45 M
63.75 M
71.36 M
—
Valuation ratios
Enterprise value
657.09 M
797.81 M
858.02 M
2.66 B
3.35 B
8.29 B
Price to earnings ratio
—
-5.46
-6.94
-15.38
-10.87
-32.74
Price to sales ratio
—
127.06
175.21
601.64
7 992.14
9 671.46
Price to cash flow ratio
—
-7.19
-7.23
-17.37
-13.49
-38.61
Price to book ratio
—
6.32
6.56
4.05
5.5
7.94
Enterprise value to EBITDA ratio
—
—
—
-15.95
-21.89
-42.65
Profitability ratios
Return on assets %
-0.39
-0.68
-0.55
-0.23
-0.41
-0.5
Return on equity %
-0.47
-1.16
-0.94
-0.26
-0.5
-0.61
Return on invested capital %
-8 665.23
-7 294.2
-5 690.71
-11.23 K
-20.44 K
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-1 278.41
-2 375.31
-2 681
-4 298.53
-77.51 K
12.86 K
EBITDA margin %
—
—
—
-4 195.83
-77.3 K
13.24 K
Net margin %
-1 211.78
-2 327.04
-2 522.73
-3 912.27
-73.62 K
12.8 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.73
4.91
7.71
25.67
13.64
70.55
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.03
0.04
0.02
0.01
0
0
Solvency ratios
Debt to assets ratio
0.17
0.24
0.31
0.08
0.11
0.48
Debt to equity ratio
0.2
0.41
0.53
0.09
0.13
0.59
Long term debt to total assets ratio
0.06
0.19
0.28
0.08
0.1
0.46
Long term debt to total equity ratio
0.07
0.32
0.49
0.09
0.12
0.57
Per share metrics
Operating cash flow per share
—
-2.54
-2.16
-2.43
-3.75
-3.77
EBIT per share
—
-3.28
-2.3
-2.95
-4.9
-4.93
EBITDA per share
—
—
—
-2.95
-4.9
-4.92
Total debt per share
—
1.18
1.26
0.99
1.2
4.48
Cash per share
—
4.32
3.76
11.58
11.12
36.91
Net current asset value per share
—
4.73
4.03
11.77
11.35
37.83
Tangible book value per share
—
2.89
2.38
10.43
9.21
31.2
Working capital per share
—
3.77
3.51
11.31
10.52
35.47
Book value per share
—
2.89
2.38
10.43
9.21
31.2
Haberler
Vera Therapeutics, Jane Wright-Mitchell’ı hukuk müdürü atadı
Wolfe Research, Vera Therapeutics hissesini değerleme üzerinden yükseltti
Wolfe Research upgrades Vera Therapeutics stock rating on valuation
BofA Securities, Vera Therapeutics için Al tavsiyesini yineledi
Vera Therapeutics stock rating reaffirmed at Buy by BofA Securities
Vera Therapeutics, Inc. (VERA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Vera Therapeutics adds Christopher Hite to board of directors
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026 - TipRanks.com
Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)
VeraDermics is said to draw IPO anchor order from Eli Lilly - Bloomberg
Vera Therapeutics, Matt Skelton’u ticari operasyonlar direktörü olarak terfi ettirdi
Vera Therapeutics promotes Matt Skelton to chief commercial officer